M

Marmara University Medical Faculty | Pediatric Nephrology

Research site
(Unclaimed)
Location
Fevzi Cakmak Mahallesi, Muhsin Yazicioglu Caddesi N. 10 Pendik, Istanbul, Istanbul, Turkey

Site insights

Top conditions

Top treatments

Guselkumab
Macitentan
NNC0195-0092
Ziltivekimab
LY2835219
Somapacitan
Selexipag
Tadalafil
Abemaciclib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 13 total trials

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer (Next MONARCH 1)

The main purpose of this study is to evaluate the safety and efficacy of abemaciclib plus tamoxifen or abemaciclib alone in women with previously tre...

Active, not recruiting
Metastatic Breast Cancer
Drug: Abemaciclib
Drug: Prophylactic Loperamide

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of gus...

Active, not recruiting
Crohn's Disease
Drug: Ustekinumab
Drug: Guselkumab Dose 3

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivek...

Not yet enrolling
Acute Myocardial Infarction (AMI)
Cardiovascular Risk
Drug: Placebo
Drug: Ziltivekimab
Locations recently updated

Combination therapy in pulmonary arterial hypertension (PAH) has been the subject of active investigation for more than a decade, with the benefit of...

Active, not recruiting
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Drug: Placebo tadalafil
Drug: Macitentan 10 mg

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) and inadequate re...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

This trial is conducted globally. The aim of the trial is to investigate efficacy and safety of once-weekly NNC0195-0092 (somapacitan) treatment comp...

Enrolling
Growth Hormone Deficiency in Children
Growth Hormone Disorder
Drug: somapacitan
Drug: Norditropin® FlexPro® pen

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committe...

Enrolling
Pulmonary Arterial Hypertension
Drug: Placebo
Drug: Macitentan 75 mg

Trial sponsors

Actelion Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo
Novo Nordisk logo
Lilly logo
H
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems